Adding the advanced PET radiotracer fluciclovine to conventional imaging to help guide radiation treatments for recurrent prostate cancer can improve disease-free survival rates, a new study finds. Among patients whose prostate ...
Oct 26, 2020
0
4
A study from Winship Cancer Institute of Emory University (Winship) has the potential to change how patients whose prostate cancer recurs after prostatectomy are treated. The study will be featured in both the plenary session ...
Oct 24, 2020
0
5
Mammograms are commonly used to screen for breast cancer. In spite of easy access, conventional mammograms cannot find every tumor due to the limited image contrast mechanism.
Jul 30, 2020
0
0
Blue light has become an increasingly common component of urban outdoor lighting. But how does it impact our health? A team led by the Barcelona Institute for Global Health (ISGlobal), a center supported by the "la Caixa" ...
Jul 30, 2020
0
109
Cancer diagnosis requires a lengthy process of multiple analyses of tissue biopsies, impeding the quick and early detection of cancers. In a new study, researchers from Osaka University developed a novel imaging system that ...
Jul 23, 2020
0
1
Scientists have uncovered the genomic signature to explain why 18F-FDG imaging performs better than PSMA-targeted imaging for prostate cancer patients with low or no expression of the prostate-specific membrane antigen (PSMA). ...
Jul 23, 2020
0
2
Results from the first study using uEXPLORER to conduct total-body dynamic positron emission tomography (PET) scans in cancer patients show that it can be used to generate high-quality images of metastatic cancer. The research ...
Jul 13, 2020
0
2
Researchers have developed a new pair of agents that show exceptional effectiveness for precision diagnosis and treatment of prostate cancer in preclinical studies. The agents, which target prostate-specific membrane antigen ...
Jul 13, 2020
0
2
(HealthDay)—Black and Hispanic patients are less likely to undergo guideline-recommended imaging at diagnosis of non-small cell lung cancer, according to a study recently published in the Journal of the National Cancer ...
Jun 23, 2020
0
0
Yale doctors have developed a technique to predict whether cancer patients receiving a common chemotherapy drug are likely to experience heart failure as a result.
Jun 19, 2020
0
6
